The effect of time and temperature on viability and performance of Langerhans islets separated from Balb/c mouse after death

Ghorbani, Rostam; Jalili, Cyrus; Salahshoor, Mohammad Reza; Shiasi, Maryam

The effect of time and temperature on viability and performance of Langerhans islets separated from Balb/c mouse after death

Authors

¹ Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

² Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Tissue transplantation plays a pivotal role in the treatment of diseases. Pancreatic beta cell transplantation is the best way to obtain normal blood glucose in patients with diabetes type 1. However, it is not clear how long endocrine pancreas cells can be used for transplantation after the donor's death. The present study was conducted to analyze the performance and viability of pancreatic islet cells after death.
Materials and Methods: Pancreas was separated from Balb/c mice at different times (0, 1, 4, 6, 12, and 24 h after death) at temperatures of 4°C and 23°C, and was cultured in Roswell_Park_Memorial_Institute (RPMI) 1640. Insulin shock, MTT assay, aldehyde fuchsin staining, dithizone staining, and florescence microscopy methods were applied to analyze the performance of beta cells, cell viability, islets' diagnosis, islet cells' diagnosis, and viable and necrotic cells diagnosis, respectively.
Results: Islets of Langerhans and beta cells were diagnosed. By increasing the temperature and time, the viability and performance of beta cells decreased significantly (P < 0.05).
Conclusion: The best condition for keeping the islets of Langerhans in terms of viability and performance is 4 h after death at temperature of 4°C.

Keywords

References

1.	Fisher JE, Lillegard JB, Mckenzie TJ, Rodysill BR, Wettstein PJ, Nyberg SL. In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs. Liver Transpl 2013;19:328-35.
2.	Kaddis JS, Hanson MS, Cravens J, Qian D, Olack B, Antler M, et al. Standardized transportation of human islets: An islet cell resource center study of more than 2,000 shipments. Cell Transplant 2013;22:1101-11.
3.	Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DE. Decreased surgical risks of pancreas transplantation in the modern era. AnnSurg 2000;231:269-75.
4.	Junqueira LC, Carneiro J, Kelley RO. Basic Histology. 11 ^th ed. New York: Appleton and Lang; 2010.p773-775
5.	Fawcett DW. Bloom and Fawcett: A Textbook of Histology. 12 ^th ed. New York: Chapman and Hail; 1994.p. 603-604.
6.	Danilenko DM, Nambiar PR, Cesta MF. A brief overview of the 32 ^nd Annual STP Symposium on the Toxicologic Pathology of the Digestive Tract and Pancreas. Toxicol Pathol 2014;42:45-8.
7.	MacDonald MJ, Langberg EC, Tibell A, Sabat G, Kendrick MA, Szweda LI, et al. Identification of ATP synthase as a lipid peroxide protein adduct in pancreatic islets from humans with and without type 2 diabetes mellitus. J Clin Endocrinol Metab 2013;98:E727-31.
8.	Sánchez-Margalet V, Lucas M, Goberna R. Pancreastatin: Further evidence for its consideration as a regulatory peptide. J Mol Endocrinol 1996;16:1-8.
9.	Markmann JF, Deng S, Huang X, Desai NM, Velidedeoglu EH, Lui C, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741-50.
10.	Weimar B, Rauber K, Brendel MD, Bretzel RG, Rau WS. Percutaneous transhepatic catheterization of the portal vein: A combined CT -and fluoroscopy- guided technique. Cardiovasc Intervent Radiol 1999;22:342-4.
11.	Bellin MD, Beilman GJ, Dunn TB, Pruett TL, Chinnakotla S, Wilhelm JJ, et al. Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy. Pancreas 2013;42:317-21.
12.	Park YJ, Ao Z, Kieffer, TJ, Chen H, Safikhan N, Thompson DM, et al. The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: Implications in type 2 diabetes and islet transplantation. Diabetologia 2013;56:508-19.
13.	Mathieu C. Current limitations of islet transplantation.TansplantProc 2001;33:1707-8.
14.	Jalili C, Salahshoor MR, Pourmotabbed A, Moradi S, Roshankhah SH, Shabaniz A. The effects of aqueous extract of Boswellia serrata on hippocampal region CA1 and learning deficit in kindled rats. Res Pharm Sci 2014;9:351-8.
15.	Amoli MM, Moosavizadeh R, Larijani B. Optimizing conditions for rat pancreatic islets isolation.Cytotechnology 2005;48:75-8.
16.	Lee JJ, Yi HY, Yang JW, Shin JS, Kwon JH, Kim CW. Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. Biosci Biotechnol Biochem 2003;67:2396-401.
17.	Ferguson J, Allsopp RH, Taylor RM, Johnston ID. Isolation and long term preservation of pancreatic islets from mouse, rat and guinea pig. Diabetologia 1976;12:115-21.
18.	Qian TL, Wang XH, Liu S, Ma L, Lu Y. Fentanyl inhibits glucose- Stimulated insulin release from beta-cells in rat pancreatic islets. World J Gastroenterol2009;15:4163-9.
19.	Khanna A, Mahalingam K, Chakrabarti D, Periyasamy G. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. CellMolBiolLett 2011;16:101-13.
20.	Pace CS, Sachs G. Glucose-induced proton uptake in secretory granules of beta-cells in monolayer culture. Am J Physiol 1982;242:C382-7.
21.	Fourcade G, Colombo BM, Grégoire S, Baeyens A, Rachdi L, Guez F, et al. Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice. Diabetes 2013;62:1646-55.
22.	Anazawa T, Matsumoto S, Yonekawa Y, Loganathan G, Wilhelm JJ, Soltani SM, et al. Prediction of pancreatic tissue densities by an analytical test gradient system before purification maximizes human islet recovery for islet autotransplantation/allotransplantation. Transplantation 2011;91:508-14.
23.	Fauci AS, Braunwald E, Kasper DL, Hauser SL, editors. Harrison's principles of internal medicine. 15 ^th ed. Philadelphia: McGraw-Hill; 1998. p. 2020-80.
24.	Lacy PE, Kostionovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967;16:35-9.
25.	von Renteln D, Quaas A, Rösch T, Denzer UW, Szyrach MN, Enderle MD, et al. A novel flexible cryoprobe for EUS-guided pancreatic biopsies. Gastrointest Endosc 2013;77:784-92.
26.	Gu J, Li W, Xiao D, Wei S, Cui W, Chen, W, et al. Compound K, a final intestinal metabolite of ginsenosides, enhances insulin secretion in MIN6 pancreatic β-cells by upregulation of GLUT2. Fitoterapia 2013;87:84-8.
27.	Kinasiewicz A, Juszczak M, Pachecka J, Fiedor P. Pancreatic islet isolation using different protocols with in situ flushing and intraductal collagenase injection. Physiol Res 2004;53:327-33.
28.	O'Gorman D, Kin T, Pawlick R, Imes S, Senior PA, Shapiro AJ. Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation. Islets 2013;5:111-5.
29.	Berkovich L, Earon G, Ron I, Rimmon A, Vexler A, Lev-Ari S. Moringa oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells. BMC Complement Altern Med 2013;13:212.
30.	Tomita Y, Nihira M, Ohno Y, Sato S. Ultrastructural changes during in situ early postmortem autolysis in kidney, pancreas, liver, heart and skeletal muscle of rats. Legacy Med (Tokyo) 2004;6:25-31.
31.	Senn P, Oshima K, Teo D, Grimm C, Heller S. Robust postmortem survival of murine vestibular and cochlear stem cells. J Assoc Res Otolaryngol 2007;8:194-204.
32.	Contreras JL, Eckstein C, Smyth CA, Sellers MT, Vilatoba M, Bilbao G, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003;52:2935-42.

Advanced Biomedical Research